Keytruda Market: A Comprehensive Analysis of the Leading PD-1...

added blog Health

2026-07-15 07:09:23 -

Keytruda Market: A Comprehensive Analysis of the Leading PD-1 Inhibitor

Market Overview The Keytruda (pembrolizumab) Market is a powerhouse in the global oncology landscape, representing the leading immune checkpoint inhibitor. As a PD-1 blocker, Keytruda has revolutionized the treatment of numerous cancers by harnessing the body's own immune system to fight tumors. Its remarkably broad label, covering over 40 FDA-approved indications, has made it a cornerstone of...

0 Comments 0 Shares 12 Views 0 Reviews